Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akio Abe

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Infection and Immunity|November 23, 2006
Enteropathogenic Escherichia coli, Shigella flexneri, and Listeria monocytogenes recruit a junctional protein, zonula occludens-1, to actin tails and pedestalsMiyuki Hanajima-Ozawa, Takeshi Matsuzawa, Aya Fukui, et al.
Science (New York, N.Y.)|November 11, 2006
Microtubule-severing activity of Shigella is pivotal for intercellular spreadingSei Yoshida, Yutaka Handa, Toshihiko Suzuki, et al.
Journal of Bacteriology|April 6, 2006
Assembly of the type III secretion apparatus of enteropathogenic Escherichia coliTomoaki Ogino, Ryuta Ohno, Kachiko Sekiya, et al.
The Journal of Experimental Medicine|December 17, 2009
Bordetella evades the host immune system by inducing IL-10 through a type III effector, BopNKanna Nagamatsu, Asaomi Kuwae, Tadashi Konaka, et al.
The Journal of Antibiotics|May 27, 2008
Guadinomines, Type III secretion system inhibitors, produced by Streptomyces sp. K01-0509. I: taxonomy, fermentation, isolation and biological propertiesMasato Iwatsuki, Ryuji Uchida, Hitomi Yoshijima, et al.
The Journal of Antibiotics|May 27, 2008
Guadinomines, Type III secretion system inhibitors, produced by Streptomyces sp. K01-0509. II: physico-chemical properties and structure elucidationMasato Iwatsuki, Ryuji Uchida, Hitomi Yoshijima, et al.
Bioorganic & Medicinal Chemistry Letters|May 11, 2022
Insights into the structure-activity relationship of a type III secretion system inhibitor, aurodoxAoi Kimishima, Daichi Hagimoto, Masako Honsho, et al.
The Journal of Clinical Endocrinology and Metabolism|March 9, 2006
Elevated serum levels of pigment epithelium-derived factor in the metabolic syndromeSho-Ichi Yamagishi, Hisashi Adachi, Akio Abe, et al.
Molecular Microbiology|March 7, 2018
Tandem tyrosine phosphosites in the Enteropathogenic Escherichia coli chaperone CesT are required for differential type III effector translocation and virulenceCameron S Runte, Umang Jain, Landon J Getz, et al.
Journal of Natural Products|August 23, 2025
Construction of a New Drug and Agrochemical Candidates Screening Platform Utilizing Drug-Hypersensitive Fission Yeast to Discover Overlooked Natural ProductsAoi Kimishima, Sota Negami, Sota Honma, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Infection and Immunity|November 23, 2006
Enteropathogenic Escherichia coli, Shigella flexneri, and Listeria monocytogenes recruit a junctional protein, zonula occludens-1, to actin tails and pedestalsMiyuki Hanajima-Ozawa, Takeshi Matsuzawa, Aya Fukui, et al.
Science (New York, N.Y.)|November 11, 2006
Microtubule-severing activity of Shigella is pivotal for intercellular spreadingSei Yoshida, Yutaka Handa, Toshihiko Suzuki, et al.
Journal of Bacteriology|April 6, 2006
Assembly of the type III secretion apparatus of enteropathogenic Escherichia coliTomoaki Ogino, Ryuta Ohno, Kachiko Sekiya, et al.
The Journal of Experimental Medicine|December 17, 2009
Bordetella evades the host immune system by inducing IL-10 through a type III effector, BopNKanna Nagamatsu, Asaomi Kuwae, Tadashi Konaka, et al.
The Journal of Antibiotics|May 27, 2008
Guadinomines, Type III secretion system inhibitors, produced by Streptomyces sp. K01-0509. I: taxonomy, fermentation, isolation and biological propertiesMasato Iwatsuki, Ryuji Uchida, Hitomi Yoshijima, et al.
The Journal of Antibiotics|May 27, 2008
Guadinomines, Type III secretion system inhibitors, produced by Streptomyces sp. K01-0509. II: physico-chemical properties and structure elucidationMasato Iwatsuki, Ryuji Uchida, Hitomi Yoshijima, et al.
Bioorganic & Medicinal Chemistry Letters|May 11, 2022
Insights into the structure-activity relationship of a type III secretion system inhibitor, aurodoxAoi Kimishima, Daichi Hagimoto, Masako Honsho, et al.
The Journal of Clinical Endocrinology and Metabolism|March 9, 2006
Elevated serum levels of pigment epithelium-derived factor in the metabolic syndromeSho-Ichi Yamagishi, Hisashi Adachi, Akio Abe, et al.
Molecular Microbiology|March 7, 2018
Tandem tyrosine phosphosites in the Enteropathogenic Escherichia coli chaperone CesT are required for differential type III effector translocation and virulenceCameron S Runte, Umang Jain, Landon J Getz, et al.
Journal of Natural Products|August 23, 2025
Construction of a New Drug and Agrochemical Candidates Screening Platform Utilizing Drug-Hypersensitive Fission Yeast to Discover Overlooked Natural ProductsAoi Kimishima, Sota Negami, Sota Honma, et al.
Pageof 6